Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase II Study of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESO-Shanghai 11)
Oncologist 2021 Jan 03;[EPub Ahead of Print], L Chu, Y Chen, Q Liu, F Liang, S Wang, Q Liu, H Yu, X Wu, J Zhang, J Deng, D Ai, Z Zhu, Y Nie, K ZhaoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.